Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00515
|
|||||
Drug Name |
Maprotiline
|
|||||
Synonyms |
3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)propylmethylamine; 3-(9,10-ethanoanthracen-9(10H)-yl)-N-methylpropan-1-amine; BA-34276; Ba-34,276; Deprilept; Deprilept (TN); Dibencycladine; Ludiomil (TN); Maprotilin; Maprotilina; Maprotilina [INN-Spanish]; Maprotiline (USAN); Maprotiline [USAN:BAN:INN]; Maprotilinum; Maprotilinum [INN-Latin]; Maprotylina; Maprotylina [Polish]; N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine; N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine; Psymion (TN); TBB066626
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Antidepressants
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C20H23N
|
|||||
Canonical SMILES |
CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24
|
|||||
InChI |
InChI=1S/C20H23N/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20/h2-5,7-10,15,21H,6,11-14H2,1H3
|
|||||
InChIKey |
QSLMDECMDJKHMQ-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 10262-69-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 277.4 | Topological Polar Surface Area | 12 | ||
Heavy Atom Count | 21 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 1 | |||
XLogP |
4.6
|
|||||
PubChem CID | ||||||
PubChem SID |
10502561
, 11111502
, 11112599
, 11113802
, 11336066
, 11361305
, 11363781
, 11366343
, 11368905
, 11371545
, 11373608
, 11377067
, 11462277
, 11466374
, 11467494
, 11483954
, 11486068
, 11487955
, 11490299
, 11491850
, 11494701
, 14775197
, 17396737
, 26751977
, 28476385
, 29223122
, 46508358
, 47211277
, 47291194
, 47589054
, 47662343
, 47662542
, 47736549
, 47811030
, 47885658
, 48035199
, 48259301
, 49699342
, 49967387
, 50085871
, 50100934
, 50104649
, 5663164
, 57322094
, 74719609
, 7849638
, 7979861
, 8152515
, 85209857
, 9318
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.